India to New Zealand: Ipratropium Export Trade Route
India has recorded 30 verified shipments of Ipratropium exported to New Zealand, representing a combined trade value of $588.8K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $19.6K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 83% of total export value with 22 shipments worth $486.1K USD. On the buying side, REX MEDICAL LTD, is the largest importer in New Zealand with $218.4K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to New Zealand Ipratropium corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $588.8K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 83% of all export value, reflecting the consolidated nature of India's ipratropium manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $19.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #15 among India's top ipratropium export destinations globally.
On the import side, key buyers of Indian ipratropium in New Zealand include REX MEDICAL LTD,, REX MEDICAL LTD, REX MEDICAL LTD, and 2 others. REX MEDICAL LTD, is the single largest importer with 4 shipments valued at $218.4K USD.
